Dexcom lifts 2026 revenue outlook to $5.18B-$5.25B as it targets nearly 50% U.S. G7 15 Day conversion by year-end

EarningsG7 15 DayPositive

AI Analysis

Summary

Dexcom raised its 2026 revenue guidance to $5.18B-$5.25B and announced plans to achieve nearly 50% U.S. G7 15 Day conversion by year-end, indicating strong market adoption of its continuous glucose monitoring device.

Financial Highlights

Revenue

$5.18B-$5.25B

Guidance

2026 revenue outlook raised to $5.18B-$5.25B

Importance:6/10

Sentiment:

0.70

revenue guidanceproduct conversionmarket expansionG7 15 Day

Related Companies

$DXCM

Read the original article

Published by Seeking Alpha Healthcare on July 31, 2026 2:04 AM

Read Original